Andrew Rezvani, MD

• Chronic Myelomonocytic Leukemia
• Acute Myeloid Leukemia
• Multiple Myeloma

Dr. Rezvani is an Associate Professor of Medicine in the Division of Blood & Marrow Transplantation and Cell Therapy. He serves as the medical director of the inpatient BMT/cell therapy units at Stanford University and as Associate Clinical Chief of the Division. As a clinician, he cares for people undergoing allogeneic and autologous hematopoietic cell transplantation and other forms of cellular therapy. His research interests include optimizing the use of alternative donors for people who lack traditional fully-matched donors; the prevention and treatment of graft-vs.-host disease; the role of the microbiome in hematopoietic cell transplantation; and quality-of-care and systems improvement. He also teaches and serves as a research mentor for trainees in the Division of Blood & Marrow Transplant at Stanford.